Value-based pricing plans to go ahead

Plans for the prices of new drugs to be based on their value to the NHS are to go ahead, the DoH has said.

The government has published its response to its consultation on ‘a new value-based approach to the pricing of branded medicines’.

The response reveals that the government is keen to move to a negotiated agreement on a new pricing scheme, with discussions on the details of the plans beginning next year.

The DoH said criticisms of the initial proposals would shape its plans.

‘The responses have informed our work to map out the future process for the development of value-based pricing, and we will continue to draw on consultation responses as we further develop the value-based pricing system,’ it said.

It added: ‘Our preference for value-based pricing would be, similarly, to achieve a negotiated agreement, and we expect negotiations might begin sometime in 2012. In the meantime, as set out above, we look forward to continued positive and productive engagement with the full range of interested stakeholders.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus